Skip to content

13F-HR/A filed by Lunate Capital Ltd

Lunate Capital Ltd filed this 13F-HR/A for the quarter ended 2025-09-30, filed 2025-11-20, with 6 holding rows worth $220,719,035.

Accession
0001011438-25-000579
Filed
2025-11-20
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, amendment of type restatement, 6 entries on the cover page, a total value of $220,719,035 stated on the cover page (in dollars after the unit check, H1), rows summing to $220,719,035 with VALUE read as dollars as filed, 13F file number 028-25509. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock2,196,200$102,562,540dollars as filed
SAILPOINT INC COM78781J109Stock3,000,000$66,240,000dollars as filed
FIGURE TECHNOLOGY SOLUTIO349381103COM CL A680,000$24,731,600dollars as filed
LINEAGE INC COM53566V106REIT600,000$23,184,000dollars as filed
NEUMORA THERAPEUTICS INC.640979100COM2,124,143$3,865,940dollars as filed
REVOLUTION MEDICINES INC76155X118*W EXP 12/17/202450,000$134,955dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001011438-25-000510 superseded2025-11-10acceptance time not in the bulk data set
13F-HR/A 0001011438-25-000579this filing2025-11-20acceptance time not in the bulk data set